Chemotherapy, Biological Agents and Radiotherapy in Head and Neck Cancer

Friday 28 November 2008 - London

Preliminary Announcement and Call for Papers

Presentations are invited on the following topics:

The deadline for submission of abstracts is Friday 5 September 2008.
Abstracts should be emailed to Dr Yosef at
Proffered speakers will have free registration for the meeting.


Draft Programme

09:00	Registration and Coffee
09:35	Chairman's introduction
	Dr Hosney Yosef, Beatson West of Scotland Cancer Centre, Glasgow
09:40	Biological evidence of the benefit in using combined modality treatment with chemotherapy/biological agents and radiotherapy
	Dr Lillian Sui, Princess Margaret, Toronto, Canada
10:05	Does neo-adjuvant chemotherapy add benefit to concomitant chemo-radiotherapy?
	Prof Jean Bourhis, Institut Gustave-Roussy, Paris, France
10:30	Results of Royal Marsden dose escalation trial of chemo-IMRT in laryngopharyngeal cancer
	Dr Chris Nutting, Royal Marsden Hospital, London
10:55	Coffee Break
11:15	Chemotherapy in neo-adjuvant and adjuvant setting: the experience of EORTC
	Prof Jan Vermorken, Chairman EORTC Head & Neck Groups, Univeristy Hospital Antwerp, Belgium
11:40	Is there still a role for combing Mitomycin C with radiation in head & neck cancer
	Dr Werner Dobrowsky, Newcastle General Hospital, Newcastle upon Tyne
12:00	Debate: Neo-adjuvant and concomitant chemotherapy with radiation should now be regarded as standard treament for majority of patients with head & neck cancer
	Speaking for: Prof Jean Bourhis
	Speaking against: Prof Jan Vermorken
	Moderator: Dr Hosney Yosef
	Discussion and voting
12:30	Chemoradiotherapy for head & neck cancer: is single agent Capecitabine an alternative to Cisplatinum
	Speaker TBC
12:50	Lunch
13:35	Chairman's introduction
	Dr Charles Kelly, Newcastle General Hospital, Newcastle upon Tyne
13:40	Whether altered fractionation still has a major role to play in combination with chemotherapy & biological agents: emphasis on organ preservation
	Prof Johannes Langendijk, University Medical Center Groningen, Groningen, The Netherlands
14:05	EBV and oropharyngeal carcinoma
	Dr Lisa Lictra, Istituto Naziolale Tumori, Milan, Italy
14:25	Management of nasopharyngeal carcinoma
	Speaker TBC
14:45	Debate: 'Chemo-IMRT should be regarded as the standard treatment for locally advanced head & neck cancer'
	Speaking for: Dr Chris Nutting Speaking against: Prof Johannes Langendijk Moderator: Dr Frances Calman, St Thomas' Cancer Centre, London
15:25	Coffee break
15:45	Proffered papers
16:05	Improving morbidity of chemotherapy and radiotherapy in head & neck cancer
	Dr Gerry Robertson, Beatson West of Scotland Cancer Centre, Glasgow
16:30	Close

Please note: speakers TBC



For more information or to book for this meeting tel: +44 (0)207 307 1411

Copyright © 2008 The British Institute of Radiology
VAT registration number GB 233 7553 63